Related Experiment Video
Updated: Jul 12, 2026
07:34
Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
Published on: May 5, 2018
[Maternal diabetes and congenital malformations]
Malene Nygaard Johansen1, Ester Garne
1Syddansk Universitet, Epidemiologi, og Kolding Sygehus, Børneafdelingen. malene.johansen@get2net.dk
Ugeskrift for Laeger
|August 20, 2005
Summary
Maternal diabetes significantly increases congenital malformation risk, even with good control. Early pregnancy hyperglycemia is a key teratogen, necessitating tight glucose management and folic acid for prevention.
Area of Science:
- Obstetrics
- Endocrinology
- Teratology
Background:
- Maternal diabetes is a significant risk factor for congenital malformations.
- Maternal hyperglycemia acts as a non-specific teratogen, increasing risks even with optimal metabolic control.
- The risk of malformations shows a linear relationship with early pregnancy hyperglycemia, without a discernible threshold.
Purpose of the Study:
- To summarize the risks of congenital malformations associated with maternal diabetes.
- To highlight the teratogenic effects of maternal hyperglycemia.
- To recommend strategies for mitigating these risks.
Main Methods:
- Review of existing literature on maternal diabetes and congenital malformations.
- Analysis of the relationship between maternal hyperglycemia and malformation risk.
- Evaluation of preventative measures.
Main Results:
- Congenital malformation risk is substantially elevated in diabetic pregnancies compared to non-diabetic ones.
- The risk escalates linearly with increasing levels of maternal hyperglycemia in early pregnancy.
- Optimal metabolic control does not eliminate the elevated risk.
Conclusions:
- Close preconceptional and first-trimester diabetic control is crucial.
- Folic acid supplementation (5 mg/day) is recommended to diminish the risk of congenital malformations.
- Proactive management of maternal hyperglycemia is essential for improving pregnancy outcomes.
More Related Videos
Related Concept Videos
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...